Medical Oncologist
Paying for treatment
Will Insurance or a Government Scheme — Pay for Trastuzumab?
Trastuzumab can be covered by PM-JAY, CGHS, state government schemes, and most comprehensive private health insurance policies. Which one applies to you depends on your employment, income, and the policy you hold.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Multiple routes exist — Government schemes, private insurance, and manufacturer assistance programmes all offer potential coverage.
- Pre-authorisation is almost always required — No scheme or insurer pays automatically. Your oncologist initiates the paperwork.
- Biosimilars change the numbers — Indian-manufactured biosimilar versions approved by CDSCO have reduced the per-cycle cost significantly.
- Start the claim before your first cycle — Approvals take time. A claim submitted on cycle one may still be processing on cycle two.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Trastuzumab can be covered by PM-JAY (Ayushman Bharat), CGHS, state schemes such as Aarogyasri, and most comprehensive private health insurance policies in India. Eligibility depends on your income category, employment type, and policy terms. Your oncology team can initiate pre-authorisation before your first cycle.
Which government schemes cover trastuzumab?
PM-JAY (Ayushman Bharat) covers HER2-positive breast cancer treatment, including targeted therapy, for families listed in the Socio-Economic Caste Census or enrolled through state databases. Your oncologist submits a pre-authorisation request through the hospital's Ayushman Bharat empanelment desk.
CGHS covers trastuzumab for central government employees, pensioners, and their dependants. The treating doctor applies for prior permission from the CGHS Additional Director before the first infusion. Cycles that begin in an emergency can be self-financed and reimbursed.
Aarogyasri in Telangana and Andhra Pradesh covers certain cancer treatment packages for families with qualifying ration cards. The hospital's social worker confirms whether your diagnosis and income category fall within the current approved package list.
ECHS covers trastuzumab for ex-servicemen and their dependants at empanelled hospitals, with prior approval from the ECHS polyclinic before treatment begins. ESI-registered employees earning within the wage ceiling can access treatment at ESIC hospitals or empanelled centres on referral from an ESIC dispensary doctor.
What to gather before making a coverage claim
- Pathology report confirming HER2-positive status — most schemes require this before approving targeted therapy.
- Your oncologist's treatment plan specifying trastuzumab or its biosimilar equivalent by name.
- Your scheme card or policy document — PM-JAY golden card, CGHS card, Aarogyasri card, or insurance policy number.
- Confirmation that the treating hospital is empanelled with your scheme — schemes do not pay at non-empanelled centres.
- Income or employment proof if the scheme is means-tested (PM-JAY, Aarogyasri) or employment-based (CGHS, ECHS, ESI).
- The pre-authorisation form completed and signed by your treating oncologist — the medical team fills this, not you.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
Does private health insurance cover trastuzumab?
Most comprehensive health insurance policies in India classify trastuzumab as a covered cancer treatment. Whether yours does depends on whether the policy has a cancer-specific exclusion, a sub-limit on targeted therapy, or a waiting period for malignancies that has not yet elapsed.
Read your policy schedule for the section on cancer or critical illness cover, then contact your insurer's pre-authorisation team to confirm targeted therapy is included. Do this before the first cycle, not at the billing counter.
Policies purchased after a diagnosis may exclude that condition as a pre-existing disease. If the policy is recent, check both the waiting period and the pre-existing disease clause before assuming cover applies.
Manufacturer-linked patient assistance programmes for trastuzumab also exist. Your oncologist or the hospital's medical social worker can tell you whether you meet the financial eligibility criteria for any programme currently running.
Coverage at a glance: schemes and insurance
| Scheme or route | Who qualifies | What is typically covered | Key step before starting |
|---|---|---|---|
| PM-JAY (Ayushman Bharat) | Families in SECC database or state-enrolled lists; income-based | Targeted therapy packages for HER2+ breast cancer at empanelled hospitals | Oncologist submits pre-auth via hospital Ayushman desk |
| Aarogyasri (Telangana / AP) | Families with white or pink ration card; state income limits apply | Cancer treatment packages — eligibility confirmed by hospital coordinator | Hospital social worker checks package and submits claim |
| CGHS | Central government employees, pensioners and their dependants | Trastuzumab with prior permission; emergency cycles reimbursed | Oncologist applies to CGHS Additional Director before first infusion |
| ECHS | Ex-servicemen and their dependants | Covered at empanelled hospitals with prior approval | Prior approval from ECHS polyclinic required |
| ESI (ESIC) | Employees earning within the ESI wage ceiling, registered with ESIC | Cancer treatment at ESIC hospitals or empanelled referral centres | Referral from ESIC dispensary doctor to specialist |
| Private health insurance | Policyholders — terms vary by insurer and plan | Targeted therapy where cancer cover is included and waiting period elapsed | Call insurer pre-auth line before first cycle |
Did you know?
India is one of the few countries with multiple domestically manufactured biosimilar versions of trastuzumab, each approved by CDSCO. These biosimilars have brought the per-cycle cost down substantially compared with the originator product.
For patients without scheme or insurance coverage, the biosimilar option is worth raising explicitly with your oncologist.
Source: Central Drugs Standard Control Organisation (CDSCO), approved biosimilar register
Explore 75 more Breast Cancer Targeted Medicines topics
Drug Deep Dive: Trastuzumab (Herceptin)
- Adjuvant Trastuzumab: Why Exactly 12 Months After Surgery?
- Diet and Nutrition While on Trastuzumab
- Drug, Food and Supplement Interactions With Trastuzumab
- Fatigue, Chills and Flu-Like Symptoms After a Trastuzumab Infusion
- Fertility, Pregnancy and Contraception on Trastuzumab
- Heart Function and Trastuzumab: Understanding Your ECHO Reports
- Herceptin vs Biosimilar Trastuzumab: Are They Really the Same?
- How Does Trastuzumab Work? The Anti-HER2 Monoclonal Antibody Explained
- How Long Does Trastuzumab Take to Work?
- How Long Will You Stay on Trastuzumab?
- Subcutaneous Trastuzumab vs IV Infusion: Which Suits You Better?
- Tests and Monitoring While You Are on Trastuzumab
- Trastuzumab (Herceptin and biosimilars): The Complete Patient Guide
- Trastuzumab Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Infusion Reactions: What Happens and How They're Managed
- Trastuzumab Myths: 'It's Chemotherapy' and Other Misunderstandings
- Trastuzumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Side Effects: The Complete List and Timeline
- Trastuzumab Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab With Pertuzumab, Chemotherapy and Hormone Therapy
- Trastuzumab in Elderly Patients and Those With Other Illnesses
- When Trastuzumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Trastuzumab? HER2-Positive Breast and Gastric Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab?
- Work, Travel and Daily Life on Trastuzumab
Drug Deep Dive: Palbociclib (Ibrance)
- Diet and Nutrition While on Palbociclib
- Drug, Food and Supplement Interactions With Palbociclib
- Fatigue on Palbociclib: Why It Happens and What Genuinely Helps
- Fertility, Pregnancy and Contraception on Palbociclib
- How Does Palbociclib Work? The CDK4/6 Inhibitor Explained
- How Long Does Palbociclib Take to Work?
- How Long Will You Stay on Palbociclib?
- Low White Cell Count on Palbociclib: Expected, and Rarely Dangerous
- Mouth Sores and Infection Risk on Palbociclib
- Palbociclib (Ibrance, Palbace): The Complete Patient Guide
- Palbociclib Myths: Low Counts, Hair Loss and Stopping Early
- Palbociclib Price in India: Brand, Generic and Monthly Cost
- Palbociclib Side Effects: The Complete List and Timeline
- Palbociclib Success Rate and Survival: An Honest Look at the Numbers
- Palbociclib With Letrozole or Fulvestrant: Understanding Your Combination
- Palbociclib in Early Breast Cancer: Why It Is Not Given After Surgery
- Palbociclib in Elderly Patients and Those With Other Illnesses
- Palbociclib vs Ribociclib vs Abemaciclib: Which CDK4/6 Inhibitor?
- Taking Palbociclib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Palbociclib
- The 21-Days-On, 7-Days-Off Palbociclib Cycle Explained
- When Palbociclib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Palbociclib? Hormone-Receptor-Positive, HER2-Negative Breast Cancer
- Will Insurance or a Government Scheme Pay for Palbociclib?
- Work, Travel and Daily Life on Palbociclib
Drug Deep Dive: Trastuzumab Deruxtecan (Enhertu)
- Diet and Nutrition While on Trastuzumab Deruxtecan
- Drug, Food and Supplement Interactions With Trastuzumab Deruxtecan
- Enhertu Myths: 'It's Just Stronger Herceptin' and Cost Misconceptions
- Enhertu in Breast, Gastric and Lung Cancer: One Drug, Three Diseases
- Fertility, Pregnancy and Contraception on Trastuzumab Deruxtecan
- HER2-Low Breast Cancer: How Enhertu Created an Entirely New Patient Group
- How Does Trastuzumab Deruxtecan Work? The HER2-Directed Antibody-Drug Conjugate Explained
- How Long Does Trastuzumab Deruxtecan Take to Work?
- How Long Will You Stay on Trastuzumab Deruxtecan?
- Interstitial Lung Disease on Enhertu: The Side Effect That Needs Immediate Action
- Low Blood Counts, Hair Loss and Heart Monitoring on Enhertu
- Nausea and Vomiting on Trastuzumab Deruxtecan: Managing a High-Risk ADC
- Tests and Monitoring While You Are on Trastuzumab Deruxtecan
- Trastuzumab Deruxtecan (Enhertu): The Complete Patient Guide
- Trastuzumab Deruxtecan Infusion Day: Premedication, Duration and What to Expect
- Trastuzumab Deruxtecan Price in India: Innovator, Biosimilar and Cost Per Cycle
- Trastuzumab Deruxtecan Side Effects: The Complete List and Timeline
- Trastuzumab Deruxtecan Success Rate and Survival: An Honest Look at the Numbers
- Trastuzumab Deruxtecan in Elderly Patients and Those With Other Illnesses
- Trastuzumab Deruxtecan vs T-DM1 and Trastuzumab: How ADCs Differ
- When Trastuzumab Deruxtecan Stops Working: Resistance and What Comes Next
- Where Trastuzumab Deruxtecan Fits Alongside Chemotherapy and Hormone Therapy
- Who Is Eligible for Trastuzumab Deruxtecan? HER2-Positive and HER2-Low Breast, Gastric and Lung Cancer
- Will Insurance or a Government Scheme Pay for Trastuzumab Deruxtecan?
- Work, Travel and Daily Life on Trastuzumab Deruxtecan
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
How do I find out if my hospital is empanelled with PM-JAY?
The PM-JAY portal maintains a searchable list of empanelled hospitals by state and district. You can also ask at the hospital's reception or its Ayushman Bharat help desk — empanelled hospitals are required to display their PM-JAY registration. If the hospital where you are being treated is not empanelled, PM-JAY will not cover care there. In that situation you would need to consider a transfer to an empanelled centre or explore a different funding route.
Will the insurer pay the hospital directly or do I pay and claim later?
If your hospital is on your insurer's cashless network, the insurer settles the bill directly with the hospital after pre-authorisation is approved. If the hospital is not on the cashless network, you pay first and submit a reimbursement claim with all original bills, prescriptions, and discharge summaries. Confirm the cashless status before your first infusion — doing it at the billing counter is too late to change the arrangement.
Can I use both PM-JAY and private insurance for the same treatment?
You cannot claim the same expense twice — doing so is insurance fraud. However, if PM-JAY covers a treatment under its package rate and there is an uncovered balance, your insurer may be able to pay the shortfall depending on your policy terms. The sequencing has to be handled correctly, so discuss this with both the hospital's claims coordinator and your insurer before treatment begins, not after the bills arrive.
What should I do if my insurer rejects the pre-authorisation?
Ask for the rejection reason in writing. Common reasons include the hospital not being on the cashless network, the treatment not matching an approved package, or a waiting period that has not elapsed. Most rejections can be appealed — your oncologist can write a medical necessity letter if the ground for rejection is clinical. If the appeal is unsuccessful, ask the hospital's social work team about government schemes, manufacturer assistance programmes, or instalment arrangements with the billing department.
Does PM-JAY pay for the biosimilar or the original trastuzumab?
PM-JAY pays for approved treatment packages rather than named drugs. Within an approved package, the oncologist selects the appropriate medicine, and this is often a CDSCO-approved biosimilar because it meets the same clinical standard. If you have a clinical reason for a specific version, raise it with your oncologist, who can advise whether it can be accommodated within the package structure.
If I lose my job during treatment, does my CGHS or ESI cover stop immediately?
CGHS coverage for pensioners continues after retirement and is not employment-dependent. For serving employees, it continues while they remain in service. ESI has a continuation provision — if you have contributed for the minimum qualifying period, benefits may continue for a limited time after employment ends. The exact period depends on your contribution history, so contact your CGHS regional office or ESIC branch directly for the rules that apply to your situation.